Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

April 26, 2021

Primary Completion Date

December 30, 2025

Study Completion Date

June 30, 2026

Conditions
Cervical Cancer
Interventions
DIAGNOSTIC_TEST

Self-PAP

A single cohort of 250 patients will be recruited from among those who need a Papanicolaou (Pap) smear for routine cervical cancer screening, to perform a self-administered Pap smear immediately prior to the traditional Pap smear. Blinded assessment of both tests will be then conducted.

DIAGNOSTIC_TEST

Traditional Pap smear

A single cohort of 250 patients will be recruited from among those who need a Papanicolaou (Pap) smear for routine cervical cancer screening, to perform a self-administered Pap smear immediately prior to the traditional Pap smear. Blinded assessment of both tests will be then conducted.

Trial Locations (3)

35042

RECRUITING

Cahaba Medical Care, Centreville

35211

RECRUITING

Cahaba Medical Care - West End, Birmingham

35218

RECRUITING

Cahaba Medical Care - Ensley, Birmingham

All Listed Sponsors
collaborator

Cahaba Medical Care Foundation

OTHER

collaborator

Laboratory Corporation of America

INDUSTRY

lead

University of Alabama at Birmingham

OTHER